EcoDrugPlus

Ensembl ID : ENSCVAG00000019143
Gene Symbol: -
Cross references: -
384 Possible Orthologues:

Ensembl ID : ENSCVAG00000023255
Gene Symbol: -
Cross references: -
246 Possible Orthologues:

Ensembl ID : ENSCVAG00000019211
Gene Symbol: -
Cross references: -
208 Possible Orthologues:

Ensembl ID : ENSCVAG00000019220
Gene Symbol: -
1 Cross references
425 Possible Orthologues:

Ensembl ID : ENSCVAG00000011132
Gene Symbol: -
Cross references: -
127 Possible Orthologues:

Ensembl ID : ENSCVAG00000012336
Gene Symbol: -
Cross references: -
253 Possible Orthologues:

Ensembl ID : ENSCVAG00000004402
Gene Symbol: -
Cross references: -
256 Possible Orthologues:

Ensembl ID : ENSCVAG00000010584
Gene Symbol: -
Cross references: -
161 Possible Orthologues:

Ensembl ID : ENSCVAG00000001257
Gene Symbol: -
Cross references: -
206 Possible Orthologues:

Ensembl ID : ENSCVAG00000005595
Gene Symbol: -
Cross references: -
249 Possible Orthologues:

Ensembl ID : ENSCVAG00000001027
Gene Symbol: -
Cross references: -
198 Possible Orthologues:

Ensembl ID : ENSCVAG00000000726
Gene Symbol: -
Cross references: -
191 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).